In the past week, DXCM stock has gone down by -4.04%, with a monthly decline of -2.31% and a quarterly surge of 40.00%. The volatility ratio for the week is 2.31%, and the volatility levels for the last 30 days are 2.90% for Dexcom Inc The simple moving average for the last 20 days is 0.21% for DXCM stock, with a simple moving average of 7.87% for the last 200 days.
Is It Worth Investing in Dexcom Inc (NASDAQ: DXCM) Right Now?
Dexcom Inc (NASDAQ: DXCM) has a price-to-earnings ratio of 62.88x that is above its average ratio. Additionally, the 36-month beta value for DXCM is 1.45. There are mixed opinions on the stock, with 18 analysts rating it as a “buy,” 6 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for DXCM is 386.61M and currently, short sellers hold a 2.43% ratio of that float. The average trading volume of DXCM on July 09, 2025 was 3.94M shares.
DXCM) stock’s latest price update
The stock of Dexcom Inc (NASDAQ: DXCM) has increased by 0.99% when compared to last closing price of $82.94. Despite this, the company has experienced a -4.04% fall in its stock price over the last five trading sessions. fool.com reported 2025-07-06 that One of Warren Buffett’s famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but still appear to be excellent long-term investment opportunities.
Analysts’ Opinion of DXCM
Many brokerage firms have already submitted their reports for DXCM stocks, with Truist repeating the rating for DXCM by listing it as a “Buy.” The predicted price for DXCM in the upcoming period, according to Truist is $102 based on the research report published on June 16, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see DXCM reach a price target of $104. The rating they have provided for DXCM stocks is “Buy” according to the report published on May 30th, 2025.
Mizuho gave a rating of “Outperform” to DXCM, setting the target price at $85 in the report published on April 10th of the current year.
DXCM Trading at 0.84% from the 50-Day Moving Average
After a stumble in the market that brought DXCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.53% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DXCM starting from Stern Sadie, who sale 1,466 shares at the price of $85.06 back on Jun 26 ’25. After this action, Stern Sadie now owns 108,155 shares of Dexcom Inc, valued at $124,698 using the latest closing price.
Stock Fundamentals for DXCM
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.59 for the gross margin
The net margin for Dexcom Inc stands at 0.13. The total capital return value is set at 0.17. Equity return is now at value 23.72, with 8.09 for asset returns.
Based on Dexcom Inc (DXCM), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at 0.37. The debt to equity ratio resting at 1.14. The interest coverage ratio of the stock is 43.93.
Currently, EBITDA for the company is 945.7 million with net debt to EBITDA at 1.89. When we switch over and look at the enterprise to sales, we see a ratio of 8.32. The receivables turnover for the company is 3.59for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.
Conclusion
In conclusion, Dexcom Inc (DXCM) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
